- Home
- CRNX vs PD Comparison
CRNX vs PD Comparison
Compare CRNX & PD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- PD
- Stock Information
- Founded
- CRNX 2008
- PD 2009
- Country
- CRNX United States
- PD United States
- Employees
- CRNX N/A
- PD N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- PD Computer Software: Prepackaged Software
- Sector
- CRNX Health Care
- PD Technology
- Exchange
- CRNX Nasdaq
- PD Nasdaq
- Market Cap
- CRNX 2.8B
- PD 1.4B
- IPO Year
- CRNX 2018
- PD 2019
- Fundamental
- Price
- CRNX $28.48
- PD $15.56
- Analyst Decision
- CRNX Strong Buy
- PD Buy
- Analyst Count
- CRNX 10
- PD 12
- Target Price
- CRNX $75.00
- PD $19.50
- AVG Volume (30 Days)
- CRNX 626.1K
- PD 1.6M
- Earning Date
- CRNX 08-07-2025
- PD 05-29-2025
- Dividend Yield
- CRNX N/A
- PD N/A
- EPS Growth
- CRNX N/A
- PD N/A
- EPS
- CRNX N/A
- PD N/A
- Revenue
- CRNX $760,000.00
- PD $476,132,000.00
- Revenue This Year
- CRNX $402.12
- PD $9.60
- Revenue Next Year
- CRNX $770.88
- PD $7.56
- P/E Ratio
- CRNX N/A
- PD N/A
- Revenue Growth
- CRNX N/A
- PD 8.55
- 52 Week Low
- CRNX $24.10
- PD $13.70
- 52 Week High
- CRNX $62.53
- PD $23.11
- Technical
- Relative Strength Index (RSI)
- CRNX 34.75
- PD 52.35
- Support Level
- CRNX $29.83
- PD $13.70
- Resistance Level
- CRNX $30.85
- PD $15.46
- Average True Range (ATR)
- CRNX 1.03
- PD 0.47
- MACD
- CRNX -0.28
- PD 0.12
- Stochastic Oscillator
- CRNX 3.36
- PD 66.32
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About PD PagerDuty Inc.
PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.